Sun Yat-sen University: Diabetes Mellitus trials

The registry lists 21 Diabetes Mellitus studies with Sun Yat-sen University as lead sponsor. 3 are open to participants now and 1 have results posted.

Early Phase 1 2Phase 3 2Phase 4 7No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• New Triple Combination Therapy in Newly Diagnosed Type 2 DiabetesNot yet recruitingNCT07635953Phase 3
• A Short-Bout Combined Aerobic and Resistance Exercise Program in Older Adults With Diabetes and Probable SarcopeniaNot yet recruitingNCT07522359Not applicable
• New Triple Therapy in Newly Diagnosed Type 2 DiabetesNot yet recruitingNCT06946628Phase 3
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
• Validation of Insulin Dose Prediction Model Based on Artificial Intelligence AlgorithmTerminatedNCT07066891Not applicable
• Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 DiabetesActive, not recruitingNCT07003191
• The Effect of Meal Replacement on the Time to Reach the Blood Glucose Target in Patients With Type 2 Diabetes MellitusStatus unknownNCT05365152Not applicable
• Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIITStatus unknownNCT05084079Phase 4
• Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 DiabetesStatus unknownNCT03909555
• Information, Networks and Rewards to Optimise Adherence to Diabetic ServicesCompletedNCT03804970Not applicable
• Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes MellitusCompletedNCT03522870Not applicable
• Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 DiabetesCompletedNCT03509324Phase 4
• Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesStatus unknownNCT03196362Phase 4
• Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 DiabetesCompletedNCT03194945Phase 4
• Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetesCompletedNCT02689765Phase 4
• Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) FunctionCompletedNCT02650726Early Phase 1
• 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic PatientsStatus unknownNCT02595606Phase 4
• Purified Anthocyanins Supplementation in Type 2 Diabetes MellitusCompletedNCT02317211Early Phase 1
• Uptake of Telemedicine System Trial in Rual CantonCompletedNCT01832077
• Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 DiabetesSuspendedNCT00948324Phase 4
• Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic PatientsCompletedNCT00147836Not applicable